Open AccessNephrogenic systemic fibrosis
Author(s) -
Koratala Abhilash,
Bhatti Vikrampal
Publication year - 2017
Publication title -
clinical case reports
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.993
Subject(s) - nephrogenic systemic fibrosis , medicine , plasmapheresis , fibrosis , extracorporeal , extracorporeal photopheresis , gadolinium , pathology , kidney disease , disease , immunology , materials science , antibody , metallurgy , graft versus host disease
Nephrogenic systemic fibrosis (NSF) is a fibrosing disorder seen in patients with renal dysfunction, commonly precipitated by administration of gadolinium contrast. There is no consistently successful treatment, but oral steroids, topical dovonex, extracorporeal photopheresis, and plasmapheresis have been tried [http://www.icnfdr.org/ Last accessed: 1/6/2017]. Avoidance of gadolinium in such patients is the key to prevention.